ESR1 and breast carcinoma: Low level/absence of TLX expression in ERα-positive breast cancer and elevated expression in ERα-negative breast cancer may be due to the proposed different cellular origins of luminal and basal breast cancer sub-types, due to their origin in luminal and basal cells, respectively, or from different progenitor cells [41].